[카테고리:] 뉴스 (News)

CEO Changwon Keum presented 3billion’s AI-based genome interpretation and diagnosis system at the annual meeting of ‘MENA Organization for Rare Diseases’. held in Dubai, UAE, from March 3rd to 5th.  His presentation placed first in the oral presentation competition.

Mexico City, Mexico – 3billion recently visited major hospitals and research institutions in Mexico City to conduct seminars and meetings aimed at fostering collaboration among medical professionals. During the visit, the company held seminars on rare disease genetic testing and diagnosis at the Children’s Hospital of Mexico Federico Gomez and the National Institute of Pediatrics (INP), two of the…

3billion recently once again opened up applications for the End the Diagnostic Odyssey Grant. We are once again excited to announce the physicians and researchers that were selected as winners. It is our hope that with this grant, they can help further the understanding of their respective field of research, and result in helping future generations…

3billion has completed the installation of Illumina’s NGS sequencer, NovaSeq X. NovaSeq X is the subsequent product of NovaSeq 6000, released in 2017. The amount of DNA that can be sequenced at a time is 2.5 times that of previous models, which can produce WGS data for up to 128 patients or WES data for…

In this webinar, with a clinical genetic expert from 3billion and pediatricians from Europe, get insights into the use of genetic testing in pediatrics with examples. What content does the webinar cover?– Real-life diagnosis cases from European partners with exome sequencing– Benefits of genome sequencing in rare disease diagnosis We recommend this webinar to pediatricians…–…

The Korean startup 3billion has officially closed its Series C funding by raising $13 million. They have raised a total of $30 million since its seed round in 2017. The recent Series C round was led by Wells Investment, JW Asset, Magna Investment, Yuanta Investment, Aventures Investment, Korea Investment & Securities, and Kakao Investment. 3billion…

3billion’s WES product, 3B-EXOME, has been upgraded.These enhancements will be effective for all samples arriving after May 1, 2023. What changed? Mitochondrial genome coverageWe have now included the entire mtDNA sequence evenly in our coverage. This enhancement has improved the accuracy of analysis for mtDNA variants. Increased RPGR gene coverageWe have complemented the RPGR gene coverage with the ORF15 exon…

3billion, an AI-based rare disease genetic diagnosis startup, aims for the global market by IPO. 3billion has selected Korea Investment & Securities Co. as its representative organizer and is pushing for listing on KOSDAQ, a stock market, and the Korea Exchange trading board. Until now, 3billion has been targeting the global market by advancing AI…

3billion recently held symposiums to accelerate the diagnosis of rare diseases in Malaysia. 3billion is a Korean biotechnology company that provides genetic testing services for diagnosing rare diseases. The tour’s purpose was to go beyond being a simple service provider and interacting more closely with our collaborators, whose purpose is the diagnosis of rare diseases.…

From Dec. 13-16, 3billion met many clients locally in Morocco. We presented to eight professors and students from various departments at University Hassan2 Hospital and discussed future research projects. We discussed the introduction of Gebra, a software service, with local distributor AskYourOmics. We promised to collaborate with the Moroccan Society of Pediatric Endocrinology. We will also create great opportunities…